Table 1.

Demographic and surgical data.

Patient ID	Gender	Diagnosis	Surgery Type	PAVMs*	Surgical Option	Age at surgery (years)	Age at follow up (years)	Follo w up (mont hs)	HFD prediction (%LPA)	HFD post-op (%LPA)	HFD Error
Patient 1	F	H, PA	Revision	Left	Hep to AZ	4.7	12.8	97.8	60	56	4
Patient 2	F	H	Revision	Left	Y-graft	19.0	19.0	0.3	38	45	7
Patient 3	M	H, D	Revision	Right	Hep to AZ	11.6	15.0	40.4	100	100	0
Patient 4	F	U	Revision	Right	Y-graft	12.7	12.8	1.6	53	32	21
Patient 5	M	H, PA	Revision	Left	ECC	17.5	18.3	9.0	26	71	45
Patient 6	M	HLHS	Fontan completeon	-	ECC	1.3	4.3	35.9	17	51	34
Patient 7	M	H, HLHS,	Fontan completeon	-	Y-graft	2.6	2.6	0.2	27	48	21
Patient 8	F	PA, TH	Fontan completeon	-	Y-graft	3.0	8.3	63.7	60	77	17
Patient 9	M	PA, DILV	Fontan completeon	-	ECC	2.2	2.2	0.3	73	80	7
Patient 10	F	H	Fontan completion	-	Hep to AZ	1.1	1.1	0.3	51	56	5
Patient 11	F	H, DORV	Fontan completion	-	Hep to AZ	3.2	4.2	11.7	71	87	16
Patient 12	F	H, HLHS	Fontan completion	-	Hep to Inn	1.4	1.5	2.1	48	25	23

^*The pulmonary arteriovenous malformations (PAVMs) column indicates which lung contained the malformations. Diagnoses are abbreviated as heterotaxy (H), pulmonary atresia (PA), dextrocardia (D), hypoplastic left heart syndrome (HLHS), tricuspid hypoplasia (TH), double inlet left ventricle (DILV), unbalanced canal (U) and double outlet right ventricle (DORV). Surgical options are abbreviated as hepatic to azygous shunt (Hep to AZ), extracardiac conduit (ECC) and hepatic to innominate vein (Hep to Inn). HFD is hepatic flow distribution.